Research Article
Metabolic Tumor Volume by 18F-FDG PET/CT Can Predict the Clinical Outcome of Primary Malignant Spine/Spinal Tumors
Table 2
Factors affecting progression-free survival in the univariate and multivariate analyses.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
HR: hazard risk. 95% CI: 95% confidence interval. Progression-free survival was negatively associated with the administration of chemotherapy (), which may indicate the aggressiveness of the tumors of the patients who had chemotherapy. |